Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion. | PLoS One | 2023 | 37058459 | PubTator, text mining | PubMed |
| Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors. | Clin Cancer Res | 2023 | 37053197 | PubTator, text mining | PubMed |
| Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts. | Int J Mol Sci | 2023 | 37047804 | PubTator, text mining | PubMed |
| Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway. | Int J Mol Sci | 2023 | 37047709 | PubTator, text mining | PubMed |
| Primary Cutaneous B-Cell Lymphomas with Large Cell Morphology: A Practical Review. | Int J Mol Sci | 2023 | 37047176 | PubTator, text mining | PubMed |
| EBV and Lymphomagenesis. | Cancers (Basel) | 2023 | 37046794 | PubTator, text mining | PubMed |
| Contribution of Epstein-Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses. | Cancers (Basel) | 2023 | 37046781 | PubTator, text mining | PubMed |
| Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer. | Cancers (Basel) | 2023 | 37046620 | PubTator, text mining | PubMed |
| Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus. | Nature | 2023 | 37046089 | PubTator, text mining | PubMed |
| iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors. | Stem Cell Res Ther | 2023 | 37038186 | PubTator, text mining | PubMed |
| Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice. | Nat Commun | 2023 | 37037829 | PubTator, text mining | PubMed |
| Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. | Signal Transduct Target Ther | 2023 | 37032379 | PubTator, text mining | PubMed |
| BAFF and APRIL counterregulate susceptibility to inflammation-induced preterm birth. | Cell Rep | 2023 | 37027297 | PubTator, text mining | PubMed |
| Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study. | Int J Surg | 2023 | 37026827 | PubTator, text mining | PubMed |
| Abnormal thrombosis and neutrophil activation increase hospital-acquired sacral pressure injuries and morbidity in COVID-19 patients. | Front Immunol | 2023 | 37026002 | PubTator, text mining | PubMed |
| Role of MHC class I pathways in Mycobacterium tuberculosis antigen presentation. | Front Cell Infect Microbiol | 2023 | 37009503 | PubTator, text mining | PubMed |
| The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME). | Front Cell Dev Biol | 2023 | 37009485 | PubTator, text mining | PubMed |
| Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis. | Front Endocrinol (Lausanne) | 2023 | 37008925 | PubTator, text mining | PubMed |
| Large animal models for cardiac remuscularization studies: A methodological review. | Front Cardiovasc Med | 2023 | 37008331 | PubTator, text mining | PubMed |
| The role of NOD-like receptors in innate immunity. | Front Immunol | 2023 | 37006312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=23